Leg Support Formula
Natural health product licensed in Canada
- Other names
- Leg Health Formula, Long Live Legs, Vein Health Formula, Vein Support Formula
- Licence holder
- Bountiful Canada Vitamins ULC
- NPN or DIN-HM
- 80080186
- Status
- Active licence
- Licence date
- 21 September 2017
- Revision date
- 20 August 2021
- Form
- Comprimé, enrobé par pellicule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitis vinifera var. tinctoria Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 1,440 milligramme | 360 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Phosphate dicalcique, Laque d'aluminium jaune FD&C No. 6, Talc, Dioxyde de titane, Poly(alcool vinylique), Stéarate de magnésium, Jaune FD&C n° 6, Croscarmellose de sodium, Dioxyde de silicium, Poly(éthylène glycol), Laque d'aluminium FD&C Rouge n° 40
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Helps to relieve symptoms of mild-to-moderate chronic venous insufficiency (CVI), such as tired, heavy or swollen legs; sensation of tension or tingling, and pain in the legs. Helps reduce lower leg edema associated with mild-to-moderate chronic venous insufficiency (CVI). Clinically shown to help improve lower leg blood flow in patients suffering from non-complicated chronic venous insufficiency (CVI). Clinically shown to improve microvascular blood flow in patients with non-complicated chronic venous insufficiency (CVI).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (itching, erythema, urticaria) have been known to occur; in which case, discontinue use. Consult a doctor if you experience nausea, gastrointestinal discomfort, headache or any other adverse reactions occur.
- Contre-indications
Do not use if you are pregnant or breastfeeding.
- Précautions et mises en garde
Consult a doctor if any of the following symptoms appear: inflammation of the skin, thrombophlebitis or subcutaneous induration (i.e. thickening), severe pain, ulcers, sudden swelling of one or both legs, cardiac or renal insufficiency. If the symptom do not improve after 2 weeks of treatment, consult a doctor as edema may have alternative causes. Discontinue use and consult a healthcare practitioner if symptoms persist or worsen, or if new symptoms appear.
Source
Official Health Canada record, licence 80080186
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging